Perioperative safety and prognosis analysis of cases underwent total thoracoscopic pneumonectomy for pulmonary malignancy in single center
10.3760/cma.j.issn.1001-4497.2019.03.001
- VernacularTitle:单中心全胸腔镜下全肺切除术治疗肺恶性病变的围手术期安全性及中期预后分析
- Author:
Zhixin LI
1
;
Xuefei HU
;
Ziwei WAN
;
Jiaqi LI
;
Dong XIE
;
Gening JIANG
Author Information
1. 同济大学附属上海市肺科医院胸外科 200433
- Keywords:
Total thoracoscopic pneumonectomy;
Pulmonary malignancy;
Complication;
Survival prognosis
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2019;35(3):129-132
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the safety and efficacy of total thoracoscopic pneumonectomy for malignant lesion from a single-center pneumonectomy database.Methods A retrospectively analysis of 43 cases of malignant lesions in patients underwent total thoracoscopic pneumonectomy from surgical database of Shanghai Pulmonary Hospital from December 2013 to August 2017 was conducted,and then the mortality,complications,and disease recurrence were summarized.Results All lesions in 43 patients were pathologically comfirmed malignant,including 39 non-small cell lung cancers and 3 small cell lung cancers and 1 pulmonary metastasis.Complete thoracoscopic pneumonectomy was pedormed in 43 patients.The average operation time was (181.1 ± 68.0) min,blood loss was (146.5 t 113.6) ml,mean tube length was (8.4 ± 3.4) days.Perioperative mortality was 2.3％ (1/43).The complication rate of grade 3 or above was 16.3％.Median follow-up was 18 months,with 9 cases occuning local recurrence or distant metastasis;6 cases suffered from cancer-related death while non-cancer related death happened in 1 patient.Conclusion For selected locally advanced pulmonary malignant lesion,total thoracoscopic pneumonectomy is an alternative to open thoracic surgery with a better perioperative safety and satisfied mid-term oncologic survival.
